Glimsat MV 1mg/500mg/0.3mg Tablet
Marketer
Saturn Formulations Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimsat MV 1mg/500mg/0.3mg Tablet
DiaBetaCombo 1mg/500mg/0.3mg tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by regulating blood glucose. Administer DiaBetaCombo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-managed blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.
Uses of Glimsat MV 1mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Glimsat MV 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimsat MV 1mg/500mg/0.3mg tablets should be administered on an empty stomach.
Common Side effects of Glimsat MV 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimsat MV 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimsat MV 1mg/500mg/0.3mg tablets should be administered on an empty stomach.
How Glimsat MV 1mg/500mg/0.3mg Tablet works:
Each Glimsat MV tablet (1mg/500mg/0.3mg) contains a triple-action blend of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Glimsat MV 1mg/500mg/0.3mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimsat MV 1mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
Using Glimsat MV 1mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Preliminary evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with excessively high or low blood sugar. Refrain from driving if you experience these blood sugar levels.
KidneyUNSAFE
Patients with kidney disease should likely avoid Glimsat MV 1mg/500mg/0.3mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Glimsat MV 1mg/500mg/0.3mg Tablets is discouraged for those with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Glimsat MV 1mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Individuals with mild to moderate liver disease should typically begin with a reduced Glimsat MV 1mg/500mg/0.3mg tablet dosage; however, its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glimsat MV 1mg/500mg/0.3mg Tablet :
Should you forget a Glimsat MV 1mg/500mg/0.3mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimsat MV 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently